N/A
N=511
IVR-Enhanced Care Transition Support for Complex Patients
Congestive Heart Failure · Chronic Obstructive Pulmonary Disease
Bottom Line
View on ClinicalTrials.gov: NCT01135381 ↗Enrolled (actual)
511
Serious AEs
0.0%
Results posted
Jun 2013
Primary outcome: Primary: Re-hospitalizations — 27; 26; 8; 14 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- IVR-Enhanced Care (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Alabama at Birmingham
- Primary completion
- Mar 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Re-hospitalizations |
27; 26; 8; 14 | — |
| SECONDARY Rehospitalizations at 90 Days |
54; 48; 22; 26 | — |
| SECONDARY Community Tenure |
1.62; 1.48; 0.52; 1.6 | — |
Summary
For complex medical patients, the transition from hospital to home-based care is a vulnerable period, placing the patient at high risk for adverse events. Using a Care Transition conceptual model, the investigators propose developing and evaluating, through a randomized controlled trial, "e-Coach," an Interactive-Voice-Response-supported (IVR) Care Transition coaching intervention, focused initially on patients hospitalized with heart failure or obstructive lung disease. This trial will test the primary hypothesis that the proportion of patients with one or more re-hospitalizations during a 90-day post-discharge follow-up period will be less in an IVRsupported care transition intervention (e-Coach) compared to a "usual care" comparison group.
Eligibility Criteria
Inclusion Criteria
- CHF/COPD patients
- English-speaking
- Medicare beneficiaries
Amendment to Inclusion Criteria:
- Recruited non-Medicare eligible beneficiaries
Exclusion Criteria
- Prognosis of 6 months or less
- Cognitive impairment with no available proxy/caregiver
- No possession of a phone
Amendments to exclusion criteria:
- heart or lung transplant recipients
- dialysis patients
- individuals already in the Cystic Fibrosis program or receiving intensive monitored care
- individuals with a ventricular assist device (LVAD; RVAD; BiVAD)
- individuals utilizing a pre-paid phone service
Data sourced from ClinicalTrials.gov (NCT01135381). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.